Contrast-media-induced nephrotoxicity - Clinic and prevention;Kontrastmittel-induzierte nephropathie - Klinik und prävention

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 42, 2005, Pages 2391-2396

  Adolph, E ^a   Chatterjee, T ^a   Ince, H ^a   Eckard, H ^a   Rehders, T ^a   Kische, S ^a   Drawert, S ^a   Petzsch, M ^a   Nienaber, Christoph A ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE; ANTIRHEUMATIC AGENT; CISPLATIN; CONTRAST MEDIUM; IOPROMIDE; MANNITOL; NITRENDIPINE;

CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INCIDENCE; META ANALYSIS; NEPHROTOXICITY; PATHOGENESIS; PROPHYLAXIS; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

CONTRAST MEDIA; EMBOLISM, CHOLESTEROL; HUMANS; KIDNEY DISEASES; RISK FACTORS;

EID: 27644439001     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-918582     Document Type: Review

References (69)

1. Agmon Y, Peleg H, Greenfield Z. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94: 1069-1073
2. Andrale L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine. Kidney Int 1998; 15: 43-49
3. Aspelin P, Aubry P, Fransson S-G, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effetcs in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499
4. Bach R, Jung F. Optimales Röntgenkontrastmittel für die ambulante Koronarangio-graphie aus mikrozirkulatorischer Sicht. Herz 1998; 23: 35-41
5. Bakris GL, Lass NA, Clock D. Renal hemodynamics and radiocontrast medium-induced renal dysfunction: A role for dopamin-1 receptors. Kidney Int 1999; 56: 206-210
6. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997; 29: 465-477
7. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125
8. Barrett BJ, Carlisle EJ. Nephrotoxocity of high- and low-osmolality contrast media: a meta-analysis. Radiology 1993; 188: 171-178
9. Barrett BJ, Parfrey PS, Vasosour HM, O'Dea F, Kent G, Stone E, Reddy R, McManamon PJ. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274-1279
10. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989; 36: 730-740
11. Briguori C, Manganelli F, Scarpato P, Elia PP, Briviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298-303
12. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endo-thelin and prostaglandins in radioconstrast-induced renal artery constriction. Kidney Int 1993; 44: 1217-1223
13. Chamsuddin AA, Kowalik KJ, Bjarnason H. Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy. Am J Roentgenol 2002; 179: 591-595
14. Chu VL, Cheng JW. Fenoldopam in the prevention of contrast media-induced acute renal failure. Ann Pharmacother 2001; 35: 1278-1282
15. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649-652
16. Conlon PJ, Schwab SJ. Time to abandon nonionic contrast? J Am Soc Nephrol 1994; 5: 123-125
17. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography related renal tissue injury (The APART trial). Am J Cardiol 2002; 89: 356-360
18. Duan SB, Liu FY, Luo JA, Wu HW, Liu RH, Peng YH, Yang XL. Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat mo-del. Acta Radiol 2000; 41: 503-507
19. Erley CM, Duda SH, Schlepckow S, Koehler CM, Huppert PE, Strohmaier WL, Bohle A, Risler T, Osswald H. Adenosine antagonist theophylline prevents the re-duction of glomerular filtration rate after contrast media application. Kidney Int 1994; 45: 1425-1431
20. Forbes JM, Hewitson TD, Becker GJ, Jones CL. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney Int 2001; 59: 1333-1341
21. Harris KG, Smith TP, cragg AH, Lemke JH. Nephrotoxicity from contrast material in renal insufficiency: Ionic versus nonionic agents. Radiology 1991; 179: 849-533
22. Haylor JL, Morcos SK. Endothelin antagonism and contrast nephropathy. Kidney Int 2000; 58: 2239
23. Hentschel M, Gildein P, Brandis M, Zimmerhackl LB. Endothelin (ET-1) is involved in the contrast media induced nephrotoxicity in children with congenital heart disease. Clin Nephrol 1995; 43: 12-15
24. Hess B. Nephrologie im Alltag. Primary Care Medicine 2003; 3: 1051-1054
25. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medul-lary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991;40:632-642
26. Heyman SN, Brezis M, Greenfeld Z, Rosen S. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat Am J Kidney Dis 1989; 14: 377-385
27. Hunter D. Fenoldopam: A dopamine type-1 receptor agonist in the prevention of re-nal injury associated with the administration of intravenous contrast. J Vasc Interv Radiol 2000; 11: 396-398
28. Ide JM, Lancelot E, Pines E, Corot C. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view. Invest Radiol 2004; 39: 155-170
29. Kay J, Chow WH, Chan TM, Lo AK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. JAMA 2003; 289: 553-608
30. Koch JA, Plum J, Grabesee B, Modder U. Prostaglandin E1: a new agent for pre-vention to renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant 2000; 15: 43-49
31. Kolonko A, Wiecek A, Kokot F. The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents. J Nephrol 1998; 11: 151-156
32. Kramer BK, Kammerl M, Schweda F, Schreiber M. A primer in radiocontrast-induced nephropathy. Nephrol Dial Trasnplnat 1999; 14: 2830-2835
33. Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Ohman EM, Finn WE. N-acetylcysteine for the prevention of radiocontrats induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004; 15: 761-769
34. Kurnik BR, Allgren RL, Center FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998; 31: 674-680
35. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 1998; 13: 358-362
36. Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 1998; 53: 698-702
37. Liss P, Nygren A, Hansell P. Hypoperfusion in the renal outer medulla after injec-tion of contrast media in rats. Acta Radiol 1999; 40: 521-527
38. Liss P, Nygren A, Olsson U, Ulfendahl HR, Erikson U. Effects of contrast media and mannitol on the renal medullary blood flow and red cell aggregations in the rat kidney. Kidney Int 1996; 49: 1268-1275
39. Manske CL, Sprafka JM, Strong JH, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-620
40. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephorpathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399
41. Merten GJ, Burgess WP, Gray LV, Hollemann JH, Roush TS, Kowalehuk GJ, Bersin RM, Moore AV, III. Simonton CA, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonat. JAMA 2004; 291: 2328-2334
42. Moore RD, Steinberg EP, Rowe NR. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: Randomized clinical trial. Radiology 1992; 182: 649-652
43. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safty Commitee, European Society of Urogenital Radiology. Eur Radiol 1999; 9: 1602-1613
44. Morcos SK, Thomsen HS. Adverse reaction to iodinated contrast media. Eur Radiol 2001; 11: 1267-1279
45. Müller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Erikson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336
46. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol Dial Transplant 1989; 4: 1030-1036
47. Newaz MA, Oyekan AO. Vascular responses to endothelin-I, angiotensin-II, and u46619 in glycerol induced acute renal failure. J Cardiovasc Pharmacol 2001; 38: 569-577
48. O'Meare JJ, Dehmer GJ. Care of patients and mangement of complications after percutaneous coronary artery interventions. Ann Int Med 1997; 127: 458-471
49. Oldemeyer JB, Cichowski EK, Wurdeman RL, Packard K, Biddle W, Mooss A. Prophylactic acetylcysteine is not effective in preventing contrast-induced nephro-pathy following coronary angiography [abstract]. J Am Coll Cardiol 2003; 41: 328A
50. Pannu N, Manns B, Lee H, Tonell M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004; 65: 1366-1374
51. Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc 2000; 75: 1275-1283
52. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: Contrast-media associated nephrotoxicity and atheroembolism. A critical review. Am J Kidney Dis 1994; 24: 713-716
53. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, van Fosen DB. Nephrotoxicity of ionic and nonionic con-trast media in 1196 patients: a randomized trial. Kidney Int 1995; 47: 254-261
54. Safirstein R. Endothelin: the yin and yang of ischemic acute renal failure. Kidney Int 2001; 59: 1590-1591
55. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM. Contrast nephrotoxicity: a randomized control trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989; 320: 149-153
56. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedures. J Am Coll Cardiol 2002; 40: 1383-1387
57. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decrease in renal function induced by radiocontrast agents. N EnglJ Med 1994; 331: 1416-1420
58. Taylor AJ, Hotschkiss D, Morse RW, McCabe J. PREPARED: Preparation for angio-graphy in renal dysfunction: a randomized trial of inpatients vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998; 114: 1570-1574
59. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast agent-induced reductions in renal function by acetyl-cysteine. N Engl J Med 2000; 343: 180-184
60. Trivedi HS, Moore H, Nasr S, Aggarwal K. A randomized prospective trial to assess the role of saline hydration on the deveolpemt of contrast nephrotoxicity. Nephron 2003; 93: C29
61. Tumlin J, Mathur V. Prophylactic efficacy of feoldapam in radiocontrast nephropathy: A randomized, doubleblind, placebo-controlled trial. J Vasc Interv Radiol 2000; 11: 175-178
62. Visweswaran P, Massin EK, DuBose TD. Mannitol-induced acute renal failure. J Am Soc Nephrol 1997; 8: 1028-1033
63. Vogt B, Ferrari P, Schönholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh Do U, Uehlinger D, Frey FJ. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-698
64. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shustermann N, Schwab SJ. Exacerbation of radiocontrast nephrootoxicity by endothelin receptor antagonism. Kidney Int 2000; 59: 1590-1591
65. Weinrauch LA, Healy RW, Leland OS. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 1977; 86: 56-59
66. Weinstein JM, Heymann S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992; 62: 413-415
67. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans. Role of renia vasoconstriction. Kidney Int 1992; 41: 1408-1413
68. Yao K, Heyne N, Erley CM, Risler T, Osswald H. The selective adenosine A1 receptor antagonist KW-3902 presents radiocontrast media-induced nephropathy in rats with chronic nitric oxide defeiciency. Eur J Pharmacol 2001; 414: 99-104
69. Yoshioka T, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volumen depletion. Kidney Int 1992; 41: 1008-1011